1 |
|
|
Conditions: |
|
Type 1 Diabetes Mellitus; Type 1 Diabetes; Diabetes Mellitus, Insulin-Dependent; Juvenile Diabetes |
Interventions: |
|
Drug: PROCHYMAL™; Drug: Placebo |
|
2 |
|
|
Conditions: |
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes Mellitus, Gestational |
Interventions: |
|
Device: GlucoMON NSR Investigational Device; Behavioral: Real-Time Glucose Alerts to Remote Caregivers |
|
3 |
|
|
Conditions: |
|
Type 2 Diabetes Mellitus; Hypercholesterolemia; Pre-Diabetes |
Interventions: |
|
Drug: Colesevelam HCl; Drug: Metformin HCl |
|
4 |
|
|
Conditions: |
|
Pediatrics; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus |
Intervention: |
|
|
|
5 |
|
|
Conditions: |
|
Diabetes Mellitus; Endocrine System Diseases; Diabetes Mellitus, Type 2; Nutritional and Metabolic Diseases |
Intervention: |
|
Drug: R256918 |
|
6 |
|
|
Conditions: |
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Intervention: |
|
Procedure: Autologous bone marrow mononuclear cell transplantation |
|
7 |
|
|
Conditions: |
|
Diabetes Mellitus, Type II; Diabetes Mellitus, Non Insulin Dependent |
Interventions: |
|
Drug: JNJ-28431754; Drug: JNJ-28431754; Drug: JNJ-28431754; Drug: JNJ-28431754; Drug: JNJ-28431754; Drug: sitagliptin; Drug: placebo |
|
8 |
|
|
Conditions: |
|
Type 2 Diabetes Mellitus, Non Insulin Dependent.; Diabetes Mellitus, Non-Insulin-Dependent |
Interventions: |
|
Drug: Comparator: sitagliptin phosphate; Drug: Comparator: glimepiride |
|
9 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Interventions: |
|
Drug: Metformin; Behavioral: Lifestyle intervention - diet, physical activity |
|
10 |
|
|
Condition: |
|
Diabetes Mellitus, Type 1 |
Intervention: |
|
Drug: Oral Insulin |
|
11 |
|
|
Conditions: |
|
Pregnancy; Pregnancy in Diabetes; Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus; Macrosomia |
Interventions: |
|
Other: blood tests; Other: diet questionnaire; Other: umbilical cord blood collect; Other: placenta collect |
|
12 |
|
|
Conditions: |
|
Gestational Diabetes; Type 2 Diabetes; Pregnancy |
Intervention: |
|
Drug: Insulin versus glucovance (glyburide/metformin) |
|
13 |
|
|
Conditions: |
|
Diabetes Mellitus; Diabetic Nephropathy |
Interventions: |
|
Drug: FG-3019; Drug: FG-3019; Drug: FG-3019 |
|
14 |
|
|
Conditions: |
|
Gestational Diabetes; Diabetes Mellitus Type 2 |
Intervention: |
|
Drug: metformin |
|
15 |
|
|
Conditions: |
|
Diabetes Mellitus; Steroid Diabetes; Glucocorticoid-Induced Diabetes; Beta-Cell Function |
Interventions: |
|
Drug: Sitagliptin 100 mg; Drug: Prednisolone 30 mg; Drug: Sitagliptin-placebo; Drug: Prednisolone-placebo |
|
16 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Interventions: |
|
Drug: rhGAD65; Drug: rhGAD65; Drug: Placebo |
|
17 |
|
|
Conditions: |
|
Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1 |
Intervention: |
|
Drug: Techonosphere Insulin Inhalation Powder |
|
18 |
|
|
Conditions: |
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy |
Interventions: |
|
Biological: SB-509; Other: Placebo |
|
19 |
|
|
Condition: |
|
Diabetes Mellitus, Type 2 |
Intervention: |
|
Behavioral: personal feedback report |
|
20 |
|
|
Condition: |
|
Type II Diabetes Mellitus |
Intervention: |
|
Procedure: gastric bypass, sleeve gastrectomy |
|
21 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Interventions: |
|
Drug: rhGAD65; Drug: rhGAD65; Drug: Placebo |
|
22 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Interventions: |
|
Drug: pioglitazone; Drug: Placebo control |
|
23 |
|
|
Conditions: |
|
Type 2 Diabetes Mellitus; Cardiovascular Disease; Obesity |
Intervention: |
|
Behavioral: Dietary Intervention (Macronutrient composition) |
|
24 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Intervention: |
|
Drug: Rosiglitazone |
|
25 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Interventions: |
|
Procedure: T Cell Proliferation and Autoreactivity Assays; Procedure: Cellular Immunoblot Assays; Procedure: Tetramer Studies; Procedure: Cytokine ELISPOT |
|
26 |
|
|
Condition: |
|
Diabetes Mellitus |
Intervention: |
|
|
|
27 |
|
|
Condition: |
|
Diabetes Mellitus |
Interventions: |
|
Biological: AMG 108; Biological: Placebo |
|
28 |
|
|
Condition: |
|
Diabetes Mellitus |
Interventions: |
|
Drug: ASP1941; Drug: Placebo |
|
29 |
|
|
Conditions: |
|
Non-Insulin-Dependent Diabetes Mellitus; Type 2 Diabetes |
Intervention: |
|
Drug: Rosiglitazone maleate/metformin hydrochloride (AVANDAMET) |
|
30 |
|
|
Condition: |
|
Diabetes Mellitus |
Intervention: |
|
Procedure: Islet Transplantation + Immunosuppression |
|
31 |
|
|
Conditions: |
|
Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
Intervention: |
|
Drug: Lubiprostone |
|
32 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Interventions: |
|
Drug: rosiglitazone; Dietary Supplement: conjugated linoleic acid (CLA); Dietary Supplement: conjugated linoleic acid (CLA) |
|
33 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Intervention: |
|
Drug: Tablet Metformin 500 mg |
|
34 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Intervention: |
|
|
|
35 |
|
|
Conditions: |
|
Atherosclerosis; Type 2 Diabetes Mellitus |
Intervention: |
|
Drug: Omacor |
|
36 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Interventions: |
|
Drug: Placebo PO, saline IV; Drug: Sitagliptin PO, saline IV; Drug: sitagliptin PO, exendin(9-39) IV; Drug: Placebo PO, exendin(9-39) IV |
|
37 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Interventions: |
|
Biological: stem cell harvest; Procedure: angiographic transplantation of stem cells |
|
38 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Interventions: |
|
Drug: CTLA-4 Ig; Other: Placebo |
|
39 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Intervention: |
|
Behavioral: Group Therapy |
|
40 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Interventions: |
|
Drug: aliskiren; Drug: irbesartan |
|
41 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Intervention: |
|
|
|
42 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Intervention: |
|
Procedure: Immunosuppresssion and autologous stem cell transplantation |
|
43 |
|
|
Condition: |
|
Type 2 Diabetes Mellitus |
Interventions: |
|
Drug: HE3286; Drug: Placebo |
|
44 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Interventions: |
|
Drug: GSK189075; Drug: placebo |
|
45 |
|
|
Condition: |
|
Diabetes Mellitus, Type 1 |
Interventions: |
|
Drug: Antithymocyte globulin; Drug: Placebo |
|
46 |
|
|
Condition: |
|
Diabetes Mellitus, Type 1 |
Interventions: |
|
Drug: IL-2; Drug: sirolimus |
|
47 |
|
|
Condition: |
|
Diabetes Mellitus, Type 2 |
Interventions: |
|
Drug: LY2189265; Drug: Sitagliptin 100mg, 24 months; Drug: Placebo solution; Drug: Placebo tablet, 6 months; Drug: Placebo tablet, 24 months; Drug: Sitagliptin 100 mg, 18 months |
|
48 |
|
|
Condition: |
|
Diabetes Mellitus |
Interventions: |
|
Drug: aspirin; Drug: Omega-3-acid Ethyl Esters |
|
49 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Intervention: |
|
|
|
50 |
|
|
Condition: |
|
Type 1 Diabetes Mellitus |
Intervention: |
|
Drug: TRX4 monoclonal antibody |
|